Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 1, 2009

Premium

Jon Faiz Kayyem has assumed the role of full-time CEO at Osmetech while the firm continues to search for a new CEO to replace former CEO James White, who stepped down in July.

Kayyem, a board member and founder of the firm's molecular diagnostics business, had been serving as a joint interm CEO with Osmetech Chairman Chris Gleeson.

Board member Mark Lappe, meantime, has resigned from his position to focus on his management consulting business, Osmetech said.


Strand Life Sciences has tapped François Mandeville for the post of executive vice president of marketing, technology, and strategy. Mandeville previously served at Hewlett-Packard and at Agilent Technologies, where he developed software for chemical analysis, life sciences, and telecommunications.


Earl Collier has resigned from his post as a director of Decode Genetics, the company said last week in a filing with the US Securities and Exchange Commission. In the filing, Decode said that the resignation was not due to any disagreements he had with the company about operations or policies.


David Barker, former chief scientific officer at Illumina, and Lynne Kielhorn, a founder of Nanodrop, will serve as advisors to nucleic acids analysis toolmaker Helixis, the firm said last month.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.